Healthcare provider profile · identity verified

Darlene Marie Cornwell

Nurse Practitioner · LUBBOCK, TX · NPI 1497094445

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	299	104
Lisinopril	Lisinopril	139	58
Atorvastatin Calcium	Atorvastatin Calcium	137	51
Amlodipine Besylate	Amlodipine Besylate	106	43
Gabapentin	Gabapentin	98	47
Metformin Hcl	Metformin Hcl	95	41
Rosuvastatin Calcium	Rosuvastatin Calcium	95	40
Simvastatin	Simvastatin	92	40
Montelukast Sodium	Montelukast Sodium	87	28
Potassium Chloride	Potassium Chloride	80	37
Losartan Potassium	Losartan Potassium	79	33
Hydrochlorothiazide	Hydrochlorothiazide	78	25
Trazodone Hcl	Trazodone Hcl	67	22
Pantoprazole Sodium	Pantoprazole Sodium	65	28
Omeprazole	Omeprazole	64	26
Escitalopram Oxalate	Escitalopram Oxalate	63	27
Tramadol Hcl	Tramadol Hcl	54	24
Alendronate Sodium	Alendronate Sodium	52	18
Olmesartan Medoxomil	Olmesartan Medoxomil	48	18
Meloxicam	Meloxicam	46	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	41
Metoprolol Succinate	Metoprolol Succinate	44	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	39
Amitriptyline Hcl	Amitriptyline Hcl	32	11
Pravastatin Sodium	Pravastatin Sodium	32	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	13
Albuterol Sulfate Hfa	Albuterol Sulfate	30	22
Estradiol	Estradiol	30	12
Fluticasone Propionate	Fluticasone Propionate	30	11
Glipizide	Glipizide	29	14
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	13
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	27	12
Allopurinol	Allopurinol	25	18
Furosemide	Furosemide	23	12
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	12
Jardiance	Empagliflozin	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Ozempic	Semaglutide	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	19
Meclizine Hcl	Meclizine Hcl	21	14
Atenolol	Atenolol	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Methylprednisolone	Methylprednisolone	19	18
Bupropion Xl	Bupropion Hcl	18	suppressed
Carvedilol	Carvedilol	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Np Thyroid	Thyroid,pork	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Ondansetron Odt	Ondansetron	15	15
Rybelsus	Semaglutide	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	13
Azelastine Hcl	Azelastine Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Premarin	Estrogens, Conjugated	14	suppressed
Cefdinir	Cefdinir	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Amoxicillin	Amoxicillin	12	11
Fluconazole	Fluconazole	12	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Naproxen	Naproxen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error